Crestor



 


 
Standard statin doses fine for South Asians in US, Canada
Wednesday, July 11, 2007
Both rosuvastatin and atorvastatin in 10 or 20 mg doses appear to be appropriate for reaching LDL...
Standard statin doses fine for South Asians in US, Canada
 
Combination therapy may help high-risk patients reach cholesterol goal
Monday, April 02, 2007
In patients at high risk for cardiovascular disease, adding ezetimibe (Zetia) to rosuvastatin...
Combination therapy may help high-risk patients reach cholesterol goal
 
Crestor slows plaque growth in low-risk patients
Monday, March 26, 2007
AstraZeneca Plc's cholesterol drug Crestor significantly slowed build-up of plaque in the main...
Crestor slows plaque growth in low-risk patients
 
RESEARCH ALERT: Analyst sees negative Crestor data
Monday, March 19, 2007
Morgan Stanley said on Friday that AstraZeneca's cholesterol fighter Crestor did not significantly...
RESEARCH ALERT: Analyst sees negative Crestor data
 
Rosuvastatin acts rapidly in acute coronary syndrome
Tuesday, January 30, 2007
The HMG-CoA reductase inhibitor rosuvastatin exerts rapid immunomodulatory effects on the level of...
Rosuvastatin acts rapidly in acute coronary syndrome
 
Rosuvastatin slows hemodynamic progression of aortic stenosis
Monday, January 29, 2007
The progression of asymptomatic aortic stenosis is slowed by treatment with rosuvastatin (Crestor),...
Rosuvastatin slows hemodynamic progression of aortic stenosis
 
Rosuvastatin improves dyslipidemia associated with antipsychotic therapy
Thursday, January 18, 2007
Rosuvastatin lowers total and low-density lipoprotein (LDL) cholesterol and triglyceride levels...
Rosuvastatin improves dyslipidemia associated with antipsychotic therapy
 
The popular cholesterol-lowering drug Crestor (Rosuvastatin) poses a greater risk of renal failure and serious adverse muscle effects which can cause liver damage and failure, kidney damage and failure, other organ failure and even death. Patients with a greater risk are those who have hypothyroidism and/or renal insufficiency as well as patients who are of Chinese or Japanese descent.

Crestor, commonly referred to as a statin, was developed by AstraZeneca, and is based on a compound discovered by a Japanese pharmaceutical company, Shionogi. Statins, such as Crestor, lower "bad" cholesterol and triglycerides and raise "good" cholesterol in the blood.

Serious side effects may include liver damage, liver failure, severe muscle damage/deterioration, kidney failure, kidney damage, other organ failure and/or death. Physical signs or symptoms of adverse reactions include but are not limited to muscle weakness, muscle tenderness, malaise, fever, dark urine, nausea or vomiting.

A consumer group, Public Citizen, filed a petition March 2004 with the FDA to remove the drug from the market. Dr. Sidney Wolfe, director of Public Citizen's Health Research Group stated to FDA Acting Commissioner Lester Crawford:  "It becomes clearer by the day that this drug is uniquely toxic and offers no unique benefit, and must be removed from the market."

Dr. David Graham, associate director for science and medicine in the FDA's Office of Drug Safety, testified November 18, 2004, before a House Committee Hearing regarding the FDA's handling of the removal of Merck's Vioxx from the market for safety reasons. Dr. Graham said the agency should take a serious look at the recently approved Crestor, which he said appears to have a risk of renal failure. He pointed out that there are already a number of other drugs in Crestor's class on the market that do not pose such a risk.

If you or a loved one have experienced any side effects from Crestor, including liver failure, liver damage, kidney failure, kidney damage, other organ failure and/or death or severe muscle damage/deterioration, please call us at 1.800.966.4999 or fill out the form to the right of the page for immediate attention to your case.


 
Schwartzapfel Partners
With over 150 years of combined experience and highly competent co-counsel throughout the country, we can serve all your legal needs. Schwartzapfel Partners protects the rights of those who aren't able to do so themselves.    Learn More



Gender: Male Female
In what state did the incident occur?

Schwartzapfel Truhowsky Marcus
       Sachs P.C. disclaimer.

Clear